Learn More About Janssen's Phase 3 COVID-19 Vaccine Candidate Study Here
Learn More
Share
Access to the Medicines, Products, Devices and Solutions You Depend On
Taking measures to ensure patients and providers have access to the medicines, products, devices and solutions they depend on
Our team at Johnson & Johnson has robust business continuity plans in place across its global supply chain network to prepare for unforeseen events like the coronavirus outbreak. These steps include maintaining critical inventory at major distribution centers away from high-risk areas and working with external suppliers to support our preparedness plans.
We are closely monitoring product demand and supply levels across our global network to ensure adequate and effective distribution and are working diligently to meet patient, customer and consumer needs. Learn more here.
Learn More About Our Efforts
More From Johnson & Johnson
June 25, 2020
The heart condition affects up to six million Americans, and raises the risk of stroke five-fold. One patient describes what it was like to learn she had atrial fibrillation—and the unexpected positive impact it has had on her life.
October 06, 2020
The iconic healthcare product is celebrating a big birthday this year: 100! To commemorate the centennial of its invention, we put together a trivia quiz that spans the last 100 years. Plus, learn about a special new partnership with CARE to help those in need.
September 23, 2020
Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
